D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
ID: 357733Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $100K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357733

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAS-25-236.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering the D-START: Data Science Track Award for Research Transition (D/START) under the R03 Small Grant Program, aimed at funding projects that utilize advanced data science techniques to investigate substance use and substance use disorders (SUD). This opportunity encourages new and established researchers to apply innovative methodologies to address critical questions in addiction research, with a focus on small-scale projects that can provide preliminary data for larger studies. The program is particularly designed to foster collaborations from underrepresented groups in STEM and aims to expedite the development of robust research programs in addiction-related data science. Applicants can request budgets of up to $100,000 for a maximum of two years, with a total of six to seven awards available, amounting to $1 million per year for fiscal years 2025 to 2027. Interested parties should submit their applications electronically through Grants.gov by the closing date of September 7, 2027, and can direct inquiries to grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAS-25-236-Full-Announcement.html
    PAS-25-236.html
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering funding for the D-START: Data Science Track Award for Research Transition (D/START) under the R03 Small Grant Program. This funding opportunity supports projects investigating substance use and substance use disorders (SUD) using advanced data science techniques. Up to six to seven awards will be given, totaling $1 million per year for fiscal years 2025 to 2027. Applicants can request budgets of up to $100,000 for a maximum of two years. The D-START program aims to encourage collaborations, particularly from underrepresented groups in STEM, and to promote innovative methodologies that improve prevention and treatment of substance-related issues. Projects may include developing predictive models, enhancing service delivery efficiency, and utilizing existing data sets to derive new insights. Applications must comply with NIH's specific guidelines and will undergo peer review based on significance, innovation, approach, and investigator qualifications. Submissions should be made electronically through Grants.gov and must be registered in various systems, including SAM and eRA Commons. The opportunity encourages quick research timelines with limited resources, fostering the development of a pipeline for future R01 grants.
    Similar Opportunities
    D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the D-START: Data Science Track Award for Research Transition (D/START), a federal grant aimed at supporting small research projects that utilize advanced data science techniques to address critical issues related to substance use and substance use disorders. This funding opportunity encourages investigators, particularly those newly entering the field or established researchers incorporating novel methodologies, to propose projects that can be executed quickly and efficiently, including pilot studies and secondary analyses of existing datasets. Grants of up to $100,000 per project per year are available for a maximum of two years, with a total of six to seven awards anticipated annually. Interested applicants should adhere to the application guidelines outlined in the NIH Application Guide, with the earliest submission date set for September 16, 2024, and applications due by 5:00 PM local time. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the AIDS-Science Track Award for Research Transition (A-START), a federal grant aimed at supporting early career investigators in the fields of drug use, substance use disorder (SUD), and HIV/AIDS research. This funding opportunity encourages applications for Small Research Grant (R03) projects that can be conducted within a short timeframe and with limited resources, focusing on innovative research that integrates substance use with HIV treatment and prevention strategies. Eligible applicants include a wide range of organizations such as higher education institutions, non-profits, and tribal governments, with funding available up to $1,000,000 over a project period not exceeding two years. Interested parties should submit their applications by January 7, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further information.
    Imaging - Science Track Award for Research Transition (I/START) (R03- Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Imaging - Science Track Award for Research Transition (I/START) grant opportunity, aimed at supporting small research projects in the field of neuroimaging, particularly related to substance use and addiction. This funding initiative encourages both new and established investigators to conduct "proof of concept" studies that can generate pilot data within a short timeframe and with limited resources. Eligible applicants include a diverse range of organizations, such as historically black colleges and universities, tribal governments, and faith-based organizations, with funding of up to $150,000 available for projects lasting a maximum of one year. Interested parties should submit their applications by January 8, 2025, and can reach out to the NIH OER Webmaster at grantsinfo@nih.gov for further assistance.
    Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Imaging - Science Track Award for Research Transition (I/START)" aimed at advancing neuroimaging methodologies relevant to substance use disorder (SUD) research. This program encourages both new and established investigators to conduct small "proof-of-concept" studies within a one-year project period, with a funding ceiling of $150,000. The initiative is designed to lower barriers for researchers in adopting advanced imaging techniques, thereby contributing to significant advancements in understanding and addressing substance use challenges. Interested applicants can find more information and application details at the provided link, with the application deadline set for January 7, 2028.
    Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Imaging - Science Track Award for Research Transition (I/START) funding opportunity, aimed at supporting small research grants (R03) in the field of neuroimaging, particularly related to substance use and substance use disorders. This initiative encourages both early-career and established researchers to adopt brain imaging methodologies for "proof of concept" studies, which are essential for generating preliminary data necessary for larger research applications. Grants of up to $150,000 are available for a one-year period, with a focus on inclusivity for underrepresented groups among eligible applicants, including various educational institutions and nonprofit organizations. Interested parties should submit their applications by January 8, 2025, and can reach out to the NIH OER Webmaster at grantsinfo@nih.gov for further assistance or inquiries regarding the application process.
    Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "Accelerating the Pace of Substance Use Research Using Existing Data." This initiative invites applications that propose innovative analyses of existing social science, behavioral, administrative, and neuroimaging data to investigate the etiology and epidemiology of substance use behaviors and related disorders, including HIV prevention and health service utilization. The program aims to leverage public datasets to enhance understanding of substance use trajectories and effective prevention strategies, particularly focusing on underrepresented populations and health disparities. A total funding commitment of $2 million is available for fiscal year 2026, with applications due by January 25, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)" to support doctoral candidates in completing their dissertation research projects related to substance use disorders. This funding initiative aims to enhance the pool of talented researchers in the field by providing grants of up to $50,000 per year for direct costs over a maximum of two years, with a focus on projects that align with the National Institute on Drug Abuse (NIDA) strategic priorities. Applications are particularly encouraged from individuals who can contribute to diversifying the research workforce, and interested candidates must submit their applications by October 16, 2023, or on February 16 and June 16, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity aimed at the development of medications to prevent and treat opioid and stimulant use disorders and overdose. This initiative seeks innovative preclinical and clinical research projects that can lead to FDA-approved therapies, focusing on areas such as prevention of substance use initiation, treatment adherence, and reduction of overdose risks. With a maximum funding amount of $3 million per year over a project period of five years, applicants are encouraged to submit proposals that demonstrate their capability to manage the research effectively, adhering to detailed application instructions. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for September 1, 2025.
    Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Mechanism for Time-Sensitive Substance Use Research" under the National Institute on Drug Abuse (NIDA). This grant, designated as R21, aims to support pilot, feasibility, and exploratory research addressing urgent issues in substance use epidemiology and health services, particularly in response to sudden increases in substance misuse and emerging public health challenges. Eligible applicants include a wide range of entities such as educational institutions, governmental bodies, and nonprofit organizations, with a budget cap of $275,000 over two years. Interested parties must submit their applications by September 9, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Accelerating the Pace of Substance Use Research Using Existing Data," aimed at supporting innovative analyses of existing datasets related to substance use behaviors, including alcohol, tobacco, and illicit drugs, and their connections to health outcomes such as HIV. This grant, classified as an R21 Clinical Trial Not Allowed, encourages applicants to utilize existing social science, behavioral, administrative, and neuroimaging data to enhance understanding of drug use behaviors, their consequences, and effective prevention and treatment strategies. A total of $2 million is available for projects over a two-year period, with individual application budgets capped at $275,000. Interested applicants must submit their proposals electronically through Grants.gov by December 3, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.